PhaseBio Pharmaceuticals
Latest round
- Series D
Last raised
- Aug 2018
Total raised
- $111M
Investors
- 10
About PhaseBio Pharmaceuticals
, based in the US, focuses on developing innovative therapies for serious diseases.PhaseBio Pharmaceuticals, Inc. is dedicated to the development of therapies for serious medical conditions, specifically leveraging its half-life extending ELP technology platform.00 mn. The CEO, Jonathan Mow, has led the company since its inception and has a background in biotechnology ventures. Notably, the company faced a restructuring process after filing for Chapter 11 bankruptcy protection in October 2022, resulting in the sale of its bentracimab program assets to SFJ Pharmaceuticals, Inc.PhaseBio Pharmaceuticals, Inc. specializes in developing innovative therapies that address critical needs in the biopharmaceutical sector. Their core product candidates focus on enhancing treatment options for serious diseases, primarily utilizing their proprietary ELP technology platform.In the most recent fiscal year 2021, PhaseBio Pharmaceuticals, Inc.PhaseBio Pharmaceuticals, Inc.00 mn to further the clinical development of its product candidates and to explore additional indications for its ELP technology platform. The company is focused on launching new therapies aimed at serious diseases, with specific emphasis on expanding its market presence in North America and Europe by 2024.
Who invested in PhaseBio Pharmaceuticals
10 investors across 12 rounds
See all investors in PhaseBio Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Aug 27, 2018
Amount
$34M
Investors
Series C
Jul 21, 2015
Amount
$1M
Investors
Series C
Mar 12, 2015
Amount
$20M
Investors
Series B
Jun 5, 2012
Amount
$23M
Investors
Series C
Dec 2, 2010
Amount
$15M
Investors
Series B
Dec 22, 2009
Amount
$10M
Investors
Series B
Apr 21, 2008
Amount
$1M
Investors
Series B
Nov 9, 2007
Amount
$5.4M
Investors
Series B
Jan 2, 2007
Amount
$1M
Investors
Series A
Aug 22, 2006
Amount
$0.3M
Investors
Series A
Apr 28, 2004
Amount
$0.1M
Investors
Series A
Feb 21, 2002
Amount
$0M
Investors
Questions about PhaseBio Pharmaceuticals
Who invested in PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals has 10 investors on record across 12 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PhaseBio Pharmaceuticals raised?
PhaseBio Pharmaceuticals has raised 12 venture rounds. Sign up free to see how much each round raised and the total.
When did PhaseBio Pharmaceuticals last raise money?
PhaseBio Pharmaceuticals's most recent round on record is a Series D, in Aug 2018.
What does PhaseBio Pharmaceuticals do?
, based in the US, focuses on developing innovative therapies for serious diseases.
Where is PhaseBio Pharmaceuticals headquartered?
PhaseBio Pharmaceuticals is headquartered in Malvern, US.
Which VCs invest in companies like PhaseBio Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at PhaseBio Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like PhaseBio Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.